|
|
| NEUE FORSCHUNGSERGEBNISSE |
|
Abnormal liver function tests in patients with Type 1 diabetes mellitus:
prevalence, clinical correlations and underlying pathologies.
AIMS: To determine the prevalence of elevated alanine transaminase (ALT) in a
large cohort of patients with Type 1 diabetes and to examine the clinical
correlations and causes. Methods Patients with Type 1 diabetes mellitus were
prospectively recruited and ALT, glycated haemoglobin and lipid profile were
measured. Patients with Type 2 diabetes mellitus were recruited as a comparison
group. PATIENTS: with abnormal ALT were investigated for underlying causes.
Prevalence of abnormal ALT was analysed at three separate cut-offs and
multivariable analysis used to identify independent risk factors. RESULTS: Nine
hundred and eleven with Type 1 diabetes and 963 with Type 2 diabetes were
included. The prevalence of elevated ALT was dependent on the cut-off value: > 30
IU/l in males and > 19 IU/l in females, > 50 and > 63 IU/l was 34.5, 4.3 and
1.9%, respectively, in Type 1 diabetes and 51.4, 8.2 and 3.7%, respectively, in
Type 2 diabetes. In Type 1 diabetes an elevated ALT was associated with worse
glycaemic control, age > 55 years and elevated triglycerides. Investigation of
these patients revealed a cause in 43.6% of patients, predominantly non-alcoholic
fatty liver disease (NAFLD). CONCLUSIONS: Elevated ALT is not uncommon in Type 1
diabetes and is associated with NAFLD-related risk factors. Patients with Type 1
diabetes and elevated ALT should be investigated as significant abnormalities may
be found which are amenable to interventions.
|
|
Autoren:
Leeds, J S
; Forman, E M
; Morley, S
; Scott, A R
; Tesfaye, S
; Sanders, D S
|
Quelle:
Diabet Med. 2009 Dec;26(12):1235-41.
|
| Literaturrecherche: U.S.National Library of Medicine's PubMed®
|
|
|

|
| |
Aktuelles
| |
| |
Produkte
| |
| |
Video-Präsentation
|
|
|